Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: Gary Korn who wrote (678)	11/16/1999 11:31:00 PM
From: blankmind	Read Replies (1) \| Respond to of 10345

"The Alzheimer's research is exciting, but it's too far off to be factored in at this stage," said Philip Molloy, analyst with ABN-AMRO Stockbrokers in Dublin. "The share price will continue to be influenced by Elan's more immediate hurdles." somehow you know this will soon be factored into the stock, but nice to know right now it is discounted, the alzhemer research. today was actually a very bullish day for eln according to thomsoninvest (enter the symbol eln), which today showed a lot of purchasing. time will tell if this pattern continues, and if accumulation is finally occurring. thomsoninvest.net